Death toll linked with weight loss and diabetic drugs rises to 82 in the UK
The United Kingdom's Medicines and Healthcare Products Regulatory Agency (MHRA) reports an increase in deaths linked to weight loss and diabetes drugs, including Mounjaro, Wegovy, and Ozempic. By January 2025, adverse reactions had resulted in 22 fatalities. Medical professionals stress the need for careful prescription and supervision to mitigate risks.
The United Kingdom's Medicines and Healthcare Products Regulatory Agency (MHRA) reports an increase in deaths linked to weight loss and diabetes drugs, including Mounjaro, Wegovy, and Ozempic. By January 2025, adverse reactions had resulted in 22 fatalities. Medical professionals stress the need for careful prescription and supervision to mitigate risks.
